Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Mark Bartlett who wrote (1630)	4/10/1999 9:59:00 PM
From: Mike McFarland	Respond to of 14101

OT Yes...SU-5416 I beleive... you could start here to start your surf... Message 8693699 There are a handful of companies which are focusing on anti-angiogenesis, recently I bought REGN, Regeneron...mainly because I figured I should own them for the neuropathy angle (also own some ntii for example) but also because I figured I'd finally get around to finding out what Ang-1,2 is all about... But there are also stocks that are hot--don't know if OSIP is running on angio related rumors, but you could dig around and see what you find. From what I can tell, the anti-angio hubbub has settled down pretty fast...although I am hoping to see some interest in MAGN soon, since Squalamine seems to generate good results in combination... but getting away from anti-angio, maybe MGI-114 is worth looking into, I have not--yet, if you can sift through the MOGN thread and come up with a summary of good recent posts, feel free to come by the Cancer thread and drop off what you find. Subject 27352 (sorry for the intrusion on this thread) --Mike